Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Míreanna comhchosúla

• Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
  de réir: Chowdhury, O, et al.
  Foilsithe / Cruthaithe: (2020)
• Profile of pomalidomide and its potential in the treatment of myelofibrosis
  de réir: Gowin KL, et al.
  Foilsithe / Cruthaithe: (2015-04-01)
• The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
  de réir: Butt, N, et al.
  Foilsithe / Cruthaithe: (2019)
• Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
  de réir: Alessandra Carobbio, et al.
  Foilsithe / Cruthaithe: (2023-07-01)
• P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
  de réir: J.-J. Kiladjian, et al.
  Foilsithe / Cruthaithe: (2022-06-01)